Brazil researchers report disappointing 50.4% efficacy for China's CoronaVac vaccine
- 3 years ago
- Updates
A coronavirus vaccine developed by China’s Sinovac Biotech was just 50.4% effective at preventing symptomatic infections in a Brazilian
Breaking News
coronavac
-
-
CoronaVac efficacy at 50-90% in Brazilian trial - Sao Paulo official
- 3 years ago
- Updates
The CoronaVac COVID-19 vaccine developed by China’s Sinovac Biotech Ltd showed efficacy between 50% and 90% in Brazilian trials, Sao
-
-
Moderna Vs Pfizer: When Will The Vaccines Be Ready?
- 3 years ago
- Updates
Coronavirus vaccines: US regulators earlier this year released guidance that said any shot should be at least 50% effective. The
Loading more postNews
Blog
-
Which Jacket Type Fits Your Personality?
- 3 years ago
-
Things to do this weekend: July 15 - 17
- 3 years ago
